Jones Day – MSQ Global Biopharma Symposium & Networking Reception
The Jones Day – MSQ Global Biopharma Symposium & Networking Reception will return to San Francisco, California!
Co-hosted by Jones Day & MSQ Ventures, with our supporting organizations BioCentury Inc., The BayHelix Group, and BioAroundWorld.
Our guest lists include key industry leaders, professionals, and potential collaborators such as Merck, Daiichi Sankyo, Roche, Johnson & Johnson, Jiangsu Hengrui, Shanghai Henlius Biotech, Neushen Therapeutics, Panacea Ventures, Quan Capital, Sherpa Healthcare Partners, Duality Bio, Overland Pharmaceuticals, Fosun Pharma USA, Ensem Therapeutics, Captor Therapeutics, Unixell Biotechnology, Alamar Biosciences, Dermaliq Therapeutics, Enterome and many more.
Dive into discussions on the cutting-edge trends and innovations shaping the regional-global biopharma landscape. Engage in thought-provoking panels, connect with top-tier biopharma executives, and discover new avenues for business growth.
Event Date: January 7, 2024
Time: 11:30 AM – 7:00 PM
Venue: 555 California Street, San Francisco, CA
Event Agenda:
11:30am - 12:15pm: Registration, Lunch & Welcoming by Jones Day & MSQ
12:15pm - 1:15pm: Panel #1 “Navigating 2024 Capital Access, Strategic Partnerships and Cross-Border Collaboration Opportunities”
o James Huang, Founder & Managing Partner, Panacea Venture
o Ed Zhang, Co-Founder, CEO, Overland Pharmaceuticals
o Marietta Wu, Managing Director, Quan Capital 泉创资本
o Darren Cai, Founder, Sherpa Healthcare Partners
o Rong Yang, CEO, Fosun Pharma USA
1:15pm - 2:00pm: Jones Day Panel & Company Presentations
o Tom Shepherd, CEO, Captor Therapeutics
o Jones Day Panel
2:00pm - 3:00pm: Panel #2 “Lessons Learned from the 2023 Cross Border Deal Making Landscape: Positioning for 2024”
o Nikhil Mutyal, Executive Director, BD&L, Merck
o Alexandria (Alex) Cogdill, MEng, PhD, Executive Director, Global External Innovation, Global BD, Daiichi Sankyo, Inc.
o Harm-Jan Borgeld, Global Head, Asia Partnering, Roche
o Su Zhang, VP, Global Head of Business Development, Jiangsu Hengrui Pharmaceuticals Co., Ltd.
o John Zhu, CEO, Duality Biologics
3:00pm - 4:00pm: MSQ Ventures & Company Presentations
o MSQ 2024 Outlook
o Pierre Belichard, CEO, Enterome
o Leah Fung, CEO, Biotheryx, Inc.
4:00pm - 5:00pm: Panel #3 “R&D Drive for Innovation in Pursuit of First & Best-in-Class Personalized Medicine"
o Wei Wu, Principal, Venture Investments J&J Innovation-JJDC
o Ping Cao, Sr VP & CBO, Henlius | 复宏汉霖
o Joan (Huaqiong) Shen, CEO, NeuShen Therapeutics
o Shengfang Jin, Board of Director, President and CEO, Ensem Therapeutics
5:00pm - 6:00pm: Company Presentations & Closing Remarks
o Emily Tan, CEO, Unixell Biotechnology
o Oliver Schluter, CFO & Co-Founder, Dermaliq Therapeutics, Inc.
o Tod White, CFO & CBO, Alamar Biosciences, Inc.
6:00pm - 7:00pm: Post Event Networking Reception (Food & Drinks)
A confirmation email will be sent upon approval. If you would like to request an invitation, kindly reach out to us via email at event@msqventures.com.